Guidance for market authorization requirements for COVID-19 vaccines: Requirements for vaccines to address SARS-CoV-2 variants
Guidance for market authorization requirements for COVID-19 vaccines: Requirements for vaccines to address SARS-CoV-2 variants is an open dataset from Health Canada with 2 files (HTML); catalogue record updated 2021-07-27. On CanQuery you can follow the original downloads. Files are available in English and French.
Variant strains of SARS-CoV-2 are emerging that may affect the level of protection provided by currently authorized COVID-19 vaccines. As a result, manufacturers are adapting authorized COVID-19 vaccines to provide protection against infection and disease caused by virus variants.
- Publisher
- Health Canada
- Resources
- 2
- Catalogue metadata updated
- 2021-07-27
Data overview
- Formats
- HTML
- File languages
- English, French
Official sources and licences
Resources
- Guidance for market authorization requirements for COVID-19 vaccines: Requirements for vaccines to address SARS-CoV-2 variants (French, HTML) HTML · Download HTML
- Guidance for market authorization requirements for COVID-19 vaccines: Requirements for vaccines to address SARS-CoV-2 variants (English, HTML) HTML · Download HTML